ReviewInternational journal of nanomedicine2007

Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).

Lotte Dinesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.